The FDA announced on May 24, 2022, that Tandem Diabetes Care is recalling t:slim X2 insulin pumps due to software issues that could cause hypoglycemia, hyperglycemia, or diabetic ketoacidosis. Owners should contact the company for a remedy.
How to tell if you have it
- Brand: Tandem Diabetes Care
- Product: t:slim X2 insulin pump; t:slim X2 insulin pump with Dexcom G5; t:slim X2 insulin pump with Basal-IQ technology; t: slim x2 insulin pump with the Control-IQ Technology
- Quantity: 31,100 units
The hazard
The pumps may experience malfunctioning non-volatile memory, inaccurate battery life display, a touchscreen staying on, or unexpected open loop conditions. These issues can be mitigated with a software update but could result in hypoglycemia, hyperglycemia, or diabetic ketoacidosis.
Context
GovInfoNow's records show Tandem Diabetes Care has had 10 other recalls since April 23, 2018. Recent brand issues include a July 16, 2026 pairing issue with Abbott sensors and an Oct. 6, 2025 false vibration motor failure risk in the Mobi pump. Other recent recalls of similar products include Medtronic MiniMed 620G Insulin Pump Recall (Feb. 13, 2026), Medtronic MiniMed 770G Insulin Pump Recall (Feb. 13, 2026), and Medtronic MiniMed 740G Insulin Pump Recall (Feb. 13, 2026).